Virtus Fund Advisers’s Calithera Biosciences, Inc CALA Stock Holding History

Virtus Fund Advisers’s Portfolio CALA Stock Details CALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$348K	Buy	+2,083	New	+$533K	﹤0.01%	409

Other funds holding CALA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Ascend Capital Orinda, California $1.99B AUM 10.36% 1-Year Est. Return

Virtus Fund Advisers's CALA Position: Q4 2017 in Review

Virtus Fund Advisers opened a new position in Calithera Biosciences, Inc (CALA) in Q4 2017: 2,083 shares worth $348K. The stake represents ﹤0.01% of the portfolio and ranks #409 among its holdings.

112 funds tracked by Wall St. Rank hold CALA as of Q4 2017.

Virtus Fund Advisers held 2,083 shares of Calithera Biosciences, Inc worth $348K as of Q4 2017.
Calithera Biosciences, Inc was a new Virtus Fund Advisers position in Q4 2017.
Calithera Biosciences, Inc made up ﹤0.01% of Virtus Fund Advisers's portfolio in Q4 2017, its #409 holding.
112 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q4 2017.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.